Notice: This company has been marked as potentially delisted and may not be actively trading. Zafgen (ZFGN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends ZFGN vs. GYRE, SAVA, PRAX, AVDL, INVA, CALT, COGT, COLL, IRON, and OPKShould you be buying Zafgen stock or one of its competitors? The main competitors of Zafgen include Gyre Therapeutics (GYRE), Cassava Sciences (SAVA), Praxis Precision Medicines (PRAX), Avadel Pharmaceuticals (AVDL), Innoviva (INVA), Calliditas Therapeutics AB (publ) (CALT), Cogent Biosciences (COGT), Collegium Pharmaceutical (COLL), Disc Medicine (IRON), and OPKO Health (OPK). These companies are all part of the "medical" sector. Zafgen vs. Gyre Therapeutics Cassava Sciences Praxis Precision Medicines Avadel Pharmaceuticals Innoviva Calliditas Therapeutics AB (publ) Cogent Biosciences Collegium Pharmaceutical Disc Medicine OPKO Health Zafgen (NASDAQ:ZFGN) and Gyre Therapeutics (NASDAQ:GYRE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Do analysts recommend ZFGN or GYRE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zafgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AGyre Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has higher valuation and earnings, ZFGN or GYRE? Zafgen has higher earnings, but lower revenue than Gyre Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZafgenN/AN/A-$45.41M-$1.07-7.23Gyre Therapeutics$113.45M11.92-$92.93MN/AN/A Which has more risk and volatility, ZFGN or GYRE? Zafgen has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, Gyre Therapeutics has a beta of 2.05, suggesting that its share price is 105% more volatile than the S&P 500. Does the media refer more to ZFGN or GYRE? In the previous week, Zafgen's average media sentiment score of 0.00 equaled Gyre Therapeutics'average media sentiment score. Company Overall Sentiment Zafgen Neutral Gyre Therapeutics Neutral Do insiders & institutionals have more ownership in ZFGN or GYRE? 70.4% of Zafgen shares are held by institutional investors. Comparatively, 24.0% of Gyre Therapeutics shares are held by institutional investors. 14.2% of Zafgen shares are held by insiders. Comparatively, 19.5% of Gyre Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ZFGN or GYRE more profitable? Zafgen's return on equity of -51.34% beat Gyre Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ZafgenN/A -51.34% -34.55% Gyre Therapeutics N/A -197.57%-88.92% Does the MarketBeat Community believe in ZFGN or GYRE? Zafgen received 345 more outperform votes than Gyre Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformZafgenOutperform Votes34568.59% Underperform Votes15831.41% Gyre TherapeuticsN/AN/A SummaryZafgen beats Gyre Therapeutics on 5 of the 8 factors compared between the two stocks. Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZFGN vs. The Competition Export to ExcelMetricZafgenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$290.02M$7.02B$5.40B$8.53BDividend YieldN/A7.96%5.15%4.14%P/E Ratio-8.069.36112.5515.07Price / SalesN/A386.151,478.8293.55Price / CashN/A47.3339.8334.04Price / Book5.735.324.645.01Net Income-$45.41M$153.56M$119.13M$225.46M Zafgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZFGNZafgenN/A$7.74-5.8%N/A+186.6%$290.02MN/A-8.0638GYREGyre TherapeuticsN/A$14.71-1.7%N/AN/A$1.26B$111.59M0.0040SAVACassava Sciences3.7252 of 5 stars$26.00-2.0%$111.50+328.8%+70.3%$1.25BN/A-18.4430Upcoming EarningsNews CoveragePRAXPraxis Precision Medicines2.695 of 5 stars$70.03-1.4%$143.44+104.8%+375.4%$1.24B$1.77M-6.83110Upcoming EarningsAnalyst ForecastAVDLAvadel Pharmaceuticals2.9144 of 5 stars$12.91-0.1%$24.57+90.3%+45.8%$1.24B$95.15M-11.03154Analyst ForecastOptions VolumeNews CoverageINVAInnoviva1.5257 of 5 stars$19.71-0.9%N/A+55.1%$1.23B$330.50M11.95112Upcoming EarningsCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180COGTCogent Biosciences2.5603 of 5 stars$12.01+0.1%$14.67+22.1%+43.1%$1.15BN/A-4.8480Upcoming EarningsCOLLCollegium Pharmaceutical4.1051 of 5 stars$34.67-1.6%$42.60+22.9%+53.5%$1.13B$576.65M13.44210Upcoming EarningsPositive NewsIRONDisc Medicine3.7516 of 5 stars$45.60-0.7%$66.40+45.6%+2.5%$1.13BN/A-12.4378Short Interest ↓OPKOPKO Health4.6555 of 5 stars$1.52-5.0%$2.75+80.9%+20.8%$1.06B$716.37M-4.613,930Upcoming EarningsNews Coverage Related Companies and Tools Related Companies GYRE Alternatives SAVA Alternatives PRAX Alternatives AVDL Alternatives INVA Alternatives CALT Alternatives COGT Alternatives COLL Alternatives IRON Alternatives OPK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZFGN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
